Flamel Technologies S.A. (ADR) Share Price Nasdaq
Equities
US3384881096
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 162M 13.52B | Sales 2025 * | 293M 24.43B | Capitalization | 1.61B 135B |
---|---|---|---|---|---|
Net income 2024 * | -32M -2.67B | Net income 2025 * | 79M 6.59B | EV / Sales 2024 * | 9.78 x |
Net cash position 2024 * | 27.06M 2.26B | Net cash position 2025 * | 95.46M 7.96B | EV / Sales 2025 * | 5.18 x |
P/E ratio 2024 * |
-257
x | P/E ratio 2025 * |
7.26
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.1% |
Latest transcript on Flamel Technologies S.A. (ADR)
Managers | Title | Age | Since |
---|---|---|---|
Gregory Divis
CEO | Chief Executive Officer | 57 | 03/17/03 |
Thomas McHugh
DFI | Director of Finance/CFO | 59 | 02/19/02 |
Scott Macke
COO | Chief Operating Officer | - | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Ende
BRD | Director/Board Member | 55 | 01/18/01 |
Gregory Divis
CEO | Chief Executive Officer | 57 | 03/17/03 |
Mark McCamish
BRD | Director/Board Member | 72 | 05/19/05 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |